
Price
$0.00
无数据
无数据
无数据
| CAS Number | 118072-93-8 |
| Catalog Number | AG00HED6(AGN-PC-04XYS4) |
| Chemical Name | Phosphonic acid, [1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis- |
| IUPAC Name | (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid |
| InChI | InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14) |
| InChI Key | XRASPMIURGNCCH-UHFFFAOYSA-N |
| MDL Number | MFCD18426508 |
| Molecular Formula | C5H10N2O7P2 |
| Molecular Weight | 272.0896 |
| NSC Number | 721517 |
| SMILES | OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O |
| UNII | 70HZ18PH24 |
| Synonyms | 2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid,
CGP 42'446,
CGP 42446,
CGP 42446A,
CGP-42'446,
CGP-42446,
CGP42'446,
CGP42446,
zoledronate,
zoledronic acid,
zoledronic acid anhydrous,
Zometa,
Zoledronic acid,
Zoledronate,
118072-93-8,
Zometa,
Reclast,
Aclasta,
CGP 42446,
(1-Hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl)diphosphonic acid,
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid,
Zomera,
ZOL,
CGP-42446,
Aclasta and Reclast,
Orazol,
UNII-70HZ18PH24,
[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid),
Zometa (TN),
CHEMBL924,
2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid,
CHEBI:46557,
Phosphonic acid, [1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-,
[1-hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid,
70HZ18PH24,
NCGC00159521-02,
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid,
AK-81486,
(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid,
Zoledronic acid [USAN:INN:BAN],
Q-201946,
1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyldiphosphonic acid,
Phosphonic acid, (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bis-,
[1-HYDROXY-2-(1H-IMIDAZOL-1-YL)-ETHYLIDENE]BISPHOSPHONIC ACID,
Bisphosphonate 3,
Zometa Concentrate,
Zometa (Novartis),
Reclast (TN),
CGP-42446A,
Zoledronic acid [USAN:INN],
Zoledronic acid (INN),
Zoledronic Acid Anhydrous,
[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic acid,
BPH 91,
(1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl)bis(phosphonic acid),
C5H10N2O7P2,
ZOL 446,
PubChem14894,
AC1L2ACJ,
Anhydrous Zoledronic Acid,
Zoledronic Acid, Anhydrous,
AC1Q6RN3,
DSSTox_CID_22668,
DSSTox_RID_80065,
Zoledronic acid, Zoledronate,
BIDD:PXR0134,
DSSTox_GSID_42668,
SCHEMBL19054,
BIDD:GT0292,
Zoledronic Acid (Zoledronate),
GTPL3177,
JMC515594 Compound 55,
PHO012,
DTXSID0042668,
BDBM12578,
CTK8A6898,
XRASPMIURGNCCH-UHFFFAOYSA-N,
HMS2089O09,
BCP22750,
CGP-4244,
EBD33252,
KS-00000NZ4,
ZINC3803652,
Tox21_111739,
ANW-57498,
GP9100,
MFCD00867791,
NSC721517,
RTA-01011,
s1314,
STL452893,
AKOS005145739,
AB07564,
AC-1092,
AN-5259,
API0004654,
CS-1829,
DB00399,
HS-0091,
MCULE-1604726355,
NSC-721517,
RP06507,
NCGC00159521-03,
NCGC00159521-04,
NCGC00159521-05,
BC206233,
HY-13777,
SC-14082,
AB0013187,
LS-181815,
4CH-021386,
CAS-118072-93-8,
FT-0082657,
FT-0601384,
ST24033505,
Y1607,
D08689,
S00092,
Z-1463,
42181-EP2270008A1,
42181-EP2292617A1,
42181-EP2295426A1,
42181-EP2295427A1,
42181-EP2308855A1,
42181-EP2311808A1,
42181-EP2311829A1,
AB01273947-01,
AB01273947-02,
AB01273947-03,
AB01273947_04,
072Z938,
C-17113,
SR-05000001436,
I06-0710,
SR-05000001436-1,
[1-hydroxy-(1H-imidazol-1-yl)-phosphonoethyl] phos,
1-Hydroxy-2-(1-imidazolyl)ethane-1,1-diphosphonic Acid,
Z1691545083,
(1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid,
Aclasta (TN),
Zoledronic acid hydrate,
Zomera (TN),
Zoledronic Acid Teva,
BPH 91 Orazol,
Zoledronic Acid Medac,
Zoledronic Acid Mylan,
Zoledronic acid trihydrate,
Zoledronic Acid Actavis,
UNII-Y1X5LD5UCA,
Zoledronic acid monohydrate,
D0VM2L,
Zoledronic Acid Teva Pharma,
CGP 42446A,
Novartis brand of zoledronic acid,
CGP 42'446,
CGP-42'446,
CGP42446,
CID68740,
C5-H10-N2-O7-P2,
CGP42'446,
CS-O-11771,
KS-1132,
Zoledronic acid, 97% - 100MG 100mg,
A1352,
Z0031,
A11010,
C088658,
2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid,
Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid,
D000077211,
(1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate,
165800-06-6,
904894-54-8,
Phosphonic acid, P,P'-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-,
Hydrogen [(1r)-2-(3-Decyl-1h-Imidazol-3-Ium-1-Yl)-1-Hydroxy-1-Phosphonoethyl]phosphonate,
Phosphonic acid, (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bis-, trihydrate,
8PH,
|
| Complexity | 327 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 271.996g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 16 |
| Hydrogen Bond Acceptor Count | 8 |
| Hydrogen Bond Donor Count | 5 |
| Isotope Atom Count | 0 |
| Molecular Weight | 272.09g/mol |
| Monoisotopic Mass | 271.996g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 153A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -4.3 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

